CL vs. CPRX

In the year-to-date period, CL achieves a 1.40% return, which is significantly lower than CPRX's 10.54% return. Over the past 10 years, CL has underperformed CPRX with an annualized return of 5.21%, while CPRX has yielded a comparatively higher 17.43% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Colgate-Palmolive Company (CL) and Catalyst Pharmaceuticals, Inc. (CPRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current CL Sharpe Ratio is 0.33, which is lower than the CPRX Sharpe Ratio of 1.22. The chart below compares the historical Sharpe Ratios of CL and CPRX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

CL's dividend yield for the trailing twelve months is around 2.18%, while CPRX has not paid dividends to shareholders.

The maximum CL drawdown since its inception was -58.91%, smaller than the maximum CPRX drawdown of -94.25%. Use the drawdown chart below to compare losses from any high point for CL and CPRX. For additional features, visit the drawdowns tool.

The current volatility for Colgate-Palmolive Company (CL) is 9.40%, while Catalyst Pharmaceuticals, Inc. (CPRX) has a volatility of 13.15%. This indicates that CL experiences smaller price fluctuations and is considered to be less risky than CPRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Colgate-Palmolive Company and Catalyst Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.